Panitumumab Added to Docetaxel, Cisplatin and Fluoropyrimidine in Oesophagogastric Cancer: ATTAX3 Phase II Trial
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2015.440
Full Text
Open PDFAbstract
Available in full text
Date
February 11, 2016
Authors
Publisher
Springer Science and Business Media LLC